Moderna (NASDAQ: MRNA) has been one of the superstars of the coronavirus vaccine race — from a share performance and vaccine development perspective. Moderna slid as the market crashed in March, but the stock quickly recovered. As they say, timing is everything. Moderna announced the launch of…